Qiagen CFO Roland Sackers tells Bloomberg that the diagnostics company is in the hunt for a new acquisition that would register in the "three-digit million dollar range." The Dutch company has been on a buyout spree in recent years as it snaps up other diagnostic players around the world. Qiagen acquired Digene in 2007 for $1.6 billion. "The focus on our acquisitions side is clearly on content, adding more tests to the machines in the field of molecular diagnostics, but also in the field of applied testing," Sackers told the business news service. Report